ABBV

3 Cash Cows to Boost Your Confidence During the February Chill

By Josh Enomoto, InvestorPlace Contributor
What are cash cow stocks? If “Jeopardy!” ever broadcasted a category called “Market Downturn,” this may be your answer (in the form of question). By…

The 7 Best Momentum Stocks You Can Purchase Today

By Alex Sirois, InvestorPlace Contributor
Momentum stocks require a positive mindset with and an ability to catch a hot company while it moves higher

3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?

By Rich Duprey, InvestorPlace Contributor
Letting your winners run can generate portfolio returns without cutting them off by taking profits. Check out these stocks with 52-week highs.

7 Dividend Stocks Worth Holding for the Long Haul

By Alex Sirois, InvestorPlace Contributor
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

By Alex Sirois, InvestorPlace Contributor
Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves.

3 Dividend Stars Every Investor Should Own to Survive a Market Crash

By Rich Duprey, InvestorPlace Contributor
Prepare for the worst but hope for the best by buying dividend stocks for a market crash that can provide both growth and income.

7 Dividend Aristocrats That Will Pay You for Years to Come

By Alex Sirois, InvestorPlace Contributor
The Dividend Aristocrats are a strong group of stocks overall with better choices available and worse choices as well.

7 Dividend Aristocrats With Boatloads of Passive Income Potential

By Yiannis Zourmpanos, InvestorPlace Contributor
Are you looking for dividend aristocrats? Here are seven dividend aristocrats with boatloads of passive income potential.

3 Biotech Stocks Set for Breakthroughs in 2024

By Terel Miles, InvestorPlace Contributor
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.

The 3 Hottest Dividend Stocks to Watch in 2024

By Josh Enomoto, InvestorPlace Contributor
You know what I hate about the typical article about hottest dividend stocks to watch? You’re excited about adding passive income to your portfolio, only…

7 Blue-Chip Dividend Stocks to Buy Before Dec. 31

By Alex Sirois, InvestorPlace Contributor
Always a strong investment, blue-chip dividend stocks continue to make sense as 2023 draws closer to an end and 2024 nears.

7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year

By Josh Enomoto, InvestorPlace Contributor
Although a new year tends to bring optimism in the market, current vagaries warrant a discussion about bulletproof stocks to buy for 2024. To be…

3 of the Most Attractive Dividend Stocks in the Pharma Space

By Muslim Farooque, InvestorPlace Contributor
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.

The 7 Most Undervalued Growth Stocks to Buy in December

By Joel Baglole, InvestorPlace Contributor
Stocks of a lot of well-known and historically great companies are on sale right now. Many marquee names haven't shared in this year's market rally and are in the red for 2023. This presents a fantastic opportunity for investors to buy great stocks at distressed prices.

Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability

By Josh Enomoto, InvestorPlace Contributor
Although investors have some evidence of a possible economic recovery, they should still consider defensive stock picks. We just don’t know what will happen next.…

The 3 Best Cheap Stocks to Buy in December

By Joel Baglole, InvestorPlace Contributor
Investors wanting to buy low and sell high should consider a position in one of these great companies whose shares have pulled back lately.

Healthcare Gems: 3 Essential Long-Term Stock Picks

By Terel Miles, InvestorPlace Contributor
Global healthcare spending reached a record $9 trillion in 2020. Catch the ongoing benefits with these three long-term healthcare stock picks.

Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?

By William White, InvestorPlace Writer
Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie.

7 High-Dividend Stocks to Buy for a Lifetime of Passive Income

By Omor Ibne Ehsan
These high-dividend stocks are among the biggest beneficiaries of current mega trends, and investors can leverage them for big gains.
Load More